DETECTION OF RECURRENT SOFT TISSUE SARCOMAS OF EXTREMITIES
https://doi.org/10.21294/1814-4861-2017-16-2-82-89
Abstract
Treatment of advanced soft tissue sarcoma (STS) has passed a difficult and long way of evolution from amputation surgery to complex limb-salvage interventions, but the problem of local recurrence is relevant today as 100 years ago. Tactics of monitoring after treatment of STS depends on the individual risk of recurrence and should be based on simple and effective diagnostic methods. Developing of new individualized approaches to patient follow up after primary treatment of STS is extremely necessary for early detection of local recurrence and improvement of overall survival, which requires close cooperation of clinical, morphological and radiology specialists.
About the Authors
G. V. Zinovyev
N.N. Petrov Institute of Oncology
Russian Federation
Russian Federation
Zinovyev Grigoriy V. - MD, postgraduate, Scientific Department of General Oncology and Urology.
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj. E-mail: zinovevgrigory@gmail.com
G. I. Gafton
N.N. Petrov Institute of Oncology
Russian Federation
Russian Federation
Gafton Georgiy I. - MD, DSc, Head of Scientific Department of General Oncology and Urology.
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj. E-mail: doc-tor@mail.ru
E. A. Busko
N.N. Petrov Institute of Oncology
Russian Federation
Russian Federation
Busko Ekaterina A. - MD, PhD, Physician, Ultrasound diagnostics, Department of Radiation Diagnostics.
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj
A. V. Mishchenko
N.N. Petrov Institute of Oncology
Russian Federation
Russian Federation
Mishchenko Andrey V. - MD, DSc, Head of Radiation Diagnostics Department.
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj
V. V. Gridasov
N.N. Petrov Institute of Oncology
Russian Federation
Russian Federation
Gridasov Vladimir V. - MD, Physician, Department of Radiation Diagnostics.
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj
I. G. Gafton
N.N. Petrov Institute of Oncology
Russian Federation
Russian Federation
Gafton Ivan G. - MD, PhD, Physician.
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj. E-mail: gafton_ivan@mail.ru
Yu. V. Semiletova
N.N. Petrov Institute of Oncology; I.I. Mechnikov North-Western State Medical University
Russian Federation
Russian Federation
Semiletova Yulia V. - MD, PhD, Assistant of Oncology Department
68, Leningradskay Street, 197758-Saint-Petersburg, township Pesochnyjj; 41, Kirochnaya Street, 191015-Saint-Petersburg. E-mail: ssemiletov@mail.ru
References
1. Aliev M.D., Men T.Kh. The incidence of soft tissue sarcomas in Russia. Sarcomas of Bones, Soft Tissue and Skin Tumors. 2013; 3: 3–9. [in Russian]
2. Siegel R.L., Miller K.D., Jemal A. Cancer statistics. CA Cancer J Clin. 2016; 66 (1): 7–30. doi: 10.3322/caac.21332.
3. Matsko D.E. Modern ideas about the morphological classification of soft tissue sarcomas and their practical significance. Practical Oncology. 2013; 14 (2): 77–83. [in Russian]
4. Coindre J., Terrier P., Guillou L., Le Doussal V., Collin F., Ranchère D., Sastre X., Vilain M.O., Bonichon F., N’Guyen Bui B. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001; 91 (10): 1914–26.
5. Cancer Management: A Multidisciplinary Approach Medical, Surgical, & Radiation Oncology (ed 14) / Eds. P.W.T. Pisters, M. Weiss, R. Maki et al. UBM Medica LLC, 2011.
6. Fong Y., Coit D.G., Woodruff J.M., Brennan M.F. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993; 217 (1): 72–77.
7. James S.L., Davies A.M. Post-operative imaging of soft tissue sarcomas. Cancer Imaging. 2008; 8: 8–18. doi: 10.1102/1470-7330.2008.0003.
8. Teplyakov V.V., Bukharov F.D., Urlova A.N., Karpenko V.U., Derzhavin V.A., Mislevtsev I.V., Yakovleva E.C. Diagnostic and treatment mistakes in managing of soft tissue sarcoma. Sarcomas of Bones, Soft Tissue and Skin Tumors. 2012; 1: 29–35. [in Russian]
9. Frolova I.G., Kotova O.V., Tyukalov Yu.I., Velichko S.A., Bober E.E., Startseva Zh.A., Konovalov A.I., Bogoutdinova A.V. The potential value of ultrasound in diagnosis of soft tissue sarcoma (literature review). Siberian Journal of Oncology. 2015; 3: 82–89. [in Russian]
10. Vesnin A.G. Radiation diagnosis of soft tissue tumors. Practical Oncology. 2004; 5 (4): 243–249. [in Russian]
11. Semenov I.I., Zaytsev A.N., Krzhivitsiy P.I., Ponomareva A.I. Methods for diagnosis and evaluation of the extent of the spread of the process in soft tissue sarcomas. Practical Oncology. 2013; 14 (2): 87–96. [in Russian]
12. Fedorova I.V., Frolova I.G., Choynzonov E.L., Velichko S.A., Tyukalov Yu.I. Evaluation of recurrences of soft tissue sarcomas using complex ultrasonography dates. Siberian Journal of Oncology. 2011; Suppl. 2: 37–39. [in Russian]
13. Zaytsev A.N., Negustorov Yu.F., Atavina O.A., Busko E.A. Elastography in algorithms of echographic differentiation of tumors of soft tissues containing fatty tissue. Bulletin of Siberian Medicine. 2012; 5: 47. [in Russian]
14. Novikov N.E. Contrast-enhanced ultrasound. History of development and modern capabilities. Russian Electronic Journal of Radiation Diagnostics. .2012; 2 (1): 20–28. [in Russian]
15. Quaia E., Calliada F., Bertolotto M., Rossi S., Garioni L., Rosa L., Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulfurhexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology. 2004; 232 (2): 420–430.
16. Wilson S.R., Kim T.K., Jang H.J., Burns P.N. Enhancement patterns of focal liver masses: discordance between contrastenhanced sonography and contrastenhanced CT and MRI. Am J Roentgenol. 2007; 189 (1): 7–12.
17. Stramare R., Gazzola M., Coran A., Sommavilla M., Beltrame V., Gerardi M., Scattolin G., Faccinetto A., Rastrelli M., Grisan E., Montesco M.C., Rossi C.R., Rubaltelli L. Contrast-enhanced ultrasound findings in soft-tissue lesions: preliminary results. J Ultrasound. 2013; 16 (1): 21–27. doi: 10.1007/s40477-013-0005-1. eCollection 2013.
18. Zamogilnaya Y.A., Aliev M.D. Evaluation of the preoperative therapy by different methods of visualisation in patients with soft tissue sarcomas. Sarcomas of Bones, Soft Tissue and Skin Tumors. 2013; 2: 3–10. [in Russian]
19. Kransdorf M.J., Murphey M.D. Soft tissue tumors: post-treatment imaging. Radiol Clin North Am. 2006; 44: 463–72.
20. Fayad L.M., Jacobs M.A., Wang X., Carrino J.A., Bluemke D.A. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology. 2012; 265 (2): 340–356. doi: 10.1148/radiol.12111740. Review.
21. Al-Ibraheem A., Buck A.K., Benz M.R., Rudert M., Beer A.J., Mansour A., Pomykala K.L., Haller B., Juenger H., Scheidhauer K., Schwaiger M., Herrmann K. (18)Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma. Cancer. 2013; 119 (6): 1227–34. doi: 10.1002/cncr.27866.
22. Evilevitch V., Weber W.A., Tap W.D., Allen-Auerbach M., Chow K., Nelson S.D., Eilber F.R., Eckardt J.J., Elashoff R.M., Phelps M.E., Czernin J., Eilber F.C. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2008; 14 (3): 715–20. doi: 10.1158/1078-0432.CCR-07-1762.
23. Benz M.R., Czernin J., Allen-Auerbach M.S., Tap W.D., Dry S.M., Elashoff D., Chow K., Evilevitch V., Eckardt J.J., Phelps M.E., Weber W.A., Eilber F.C. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in highgrade soft-tissue sarcomas. Clin Cancer Res. 2009; 15 (8): 2856–63. doi: 10.1158/1078-0432.CCR-08-2537.
24. Eary J.F., O’Sullivan F., Powitan Y., Chandhury K.R., Vernon C., Bruckner J.D., Conrad E.U. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging. 2002; 29 (9): 1149–54.
25. Rodriguez-Alfons B., Mucientes Rasilla J., Mitjavila Casanovas M., Cardona Arboniés J., Cubedo R. 18F-FDG–PET–CT in soft tissue sarcomas: When to image? Rev Esp Med Nucl Imagen. 2014; 33 (1): 43–49. doi: 10.1016/j.remn.2013.07.005.
26. Rutkowski P., Lugowska I. Follow-up in soft tissue sarcomas. Memo. 2014; 7 (2): 92–96.
27. Chou Y.S., Liu C.Y., Chen W.M., Chen T.H., Chen P.C., Wu H.T., Chiou H.J., Shiau C.Y., Wu Y.C., Liu C.L., Chao T.C., Tzeng C.H., Yen C.C. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival. J Surg Oncol. 2012; 106 (2): 155–61. doi: 10.1002/jso.23060.
28. Whooley B.P., Gibbs J.F., Mooney M.M., McGrath B.E., Kraybill W.G. Primary extremity sarcoma: What is the appropriate follow-up? Ann Surg Oncol. 2000; 7 (1): 9–14.
29. Puri A., Gulia A., Hawaldar R., Ranganathan P., Badwe R.A. Does intensity of surveillance affect survival after surgery for sarcomas? Results of a randomized noninferiority trial. Clin Orthop Relat Res. 2014; 472 (5): 1568–1575. doi: 10.1007/s11999-013-3385-9.
30. Briccoli A., Galletti S., Salone M., Morganti A., Pelotti P., Rocca M. Ultrasonography is superior to computed tomography and magnetic resonance imaging in determining superficial resection margins of malignant chest wall tumors. J Ultrasound Med. 2007; 26 (2): 157–62.
31. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Soft Tissue Sarcomas, Version 1.2016
32. Labarre D., Aziza R., Filleronb T., Delannes M., Delaunay F., Marques B., Ferron G., Chevreau C. Detection of local recurrences of limb soft tissue sarcomas: Is magnetic resonance imaging (MRI) relevant? Eur J Radiol. 2009; 72 (1): 50–53. doi: 10.1016/j.ejrad.2009.05.027.
33. Grimer R., Judson I., Peake D., Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010; 50: 61–82. doi: 10.1155/2010/506182.
34. Ruka W., Rutkowski P., Krzakowski M. Soft tissue sarcomas in adult patients – guidelines for diagnosis and treatment. Nowotwory – J Oncol. 2010; 60: 55–65.
35. Gerrand C.H., Billingham L.J., Woll P.J., Grimer R.J. Followup after primary treatment of soft tissue sarcoma: a survey of current practice in the United Kingdom. Sarcoma. 2007; 34: 1–28. doi: 10.1155/2007/34128.
36. Brennan M.F. Follow-up is valuable and effective: true, true and unrelated? Ann Surg Oncol. 2000; 7 (1): 2–3.
Review
For citations:
Zinovyev G.V., Gafton G.I., Busko E.A., Mishchenko A.V., Gridasov V.V., Gafton I.G., Semiletova Yu.V. DETECTION OF RECURRENT SOFT TISSUE SARCOMAS OF EXTREMITIES. Siberian journal of oncology. 2017;16(2):82-89. (In Russ.) https://doi.org/10.21294/1814-4861-2017-16-2-82-89
Views:
1053
Email this article 
